DT-101 for Depression

(Tarian-1 Trial)

Recruiting at 11 trial locations

Overseen By Chief Medical Officer

Age: 18+

Sex: Any

Trial Phase: Phase 2

Sponsor: Draig Therapeutics Ltd

Prior Safety Data This treatment has passed at least one previous human trial

Compensation: Varies

Number of Visits: Unknown

300 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. Subjects will attend the clinic every couple of weeks complete general health checks and complete questionnaires.

Are You a Good Fit for This Trial?

This trial is for adults with depression, including Major Depressive Disorder. Participants must be able to visit the clinic regularly for health checks and questionnaires.

Inclusion Criteria

I am between 18 and 75 years old.

I have been diagnosed with depression more than once.

The participant is able to read, understand and communicate in the local language used at the study site, and is willing to provide written informed consent

Exclusion Criteria

I do not have any unstable medical conditions or chronic diseases.

Pregnant or breastfeeding or plans to become pregnant during the study

I have a major nerve or brain problem.

What Are the Treatments Tested in This Trial?

Interventions

• DT-101

Trial Overview

The study tests if DT-101 can treat depression compared to a placebo. Subjects will receive either DT-101 or a placebo and their progress will be monitored through regular clinic visits.

How Is the Trial Designed?

Group I: DT-101 B Experimental Treatment 1 Intervention

Group II: DT-101 A Experimental Treatment 1 Intervention

Group III: Placebo Placebo Group 1 Intervention

Who Is Running the Clinical Trial?

Draig Therapeutics Ltd

Lead Sponsor